RIVAROXABAN

Generic: RIVAROXABAN

Camber PharmaceuticalsManufacturer
ORALRoute
RIVAROXABANActive Substance
2025-05-14Original Approval

RIVAROXABAN is FDA application ANDA219332, sponsored by ASCENT PHARMS INC. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Top Reported Reactions

1
DYSPNOEA
1,578 reports
2
DRUG INTERACTION
1,575 reports
3
OFF LABEL USE
1,380 reports
4
ANAEMIA
1,360 reports
5
DRUG INEFFECTIVE
1,267 reports
6
PULMONARY EMBOLISM
1,093 reports
7
FATIGUE
1,054 reports
8
ATRIAL FIBRILLATION
998 reports
9
GASTROINTESTINAL HAEMORRHAGE
959 reports
10
DIZZINESS
942 reports